276 related articles for article (PubMed ID: 17913302)
81. Expression of functional dopaminergic phenotype in purified cultured Müller cells from vertebrate retina.
Kubrusly RC; Panizzutti R; Gardino PF; Stutz B; Reis RA; Ventura AL; de Mello MC; de Mello FG
Neurochem Int; 2008 Sep; 53(3-4):63-70. PubMed ID: 18582514
[TBL] [Abstract][Full Text] [Related]
82. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture.
Radad K; Gille G; Rausch WD
Toxicol In Vitro; 2008 Feb; 22(1):68-74. PubMed ID: 17923380
[TBL] [Abstract][Full Text] [Related]
83. 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium.
Pavlovic S; Schulze G; Wernicke C; Bonnet R; Gille G; Badiali L; Kaminska A; Lorenc-Koci E; Ossowska K; Rommelspacher H
Neuroscience; 2006; 139(4):1525-37. PubMed ID: 16517085
[TBL] [Abstract][Full Text] [Related]
84. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
85. Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo.
Paul G; Christophersen NS; Raymon H; Kiaer C; Smith R; Brundin P
Mol Cell Neurosci; 2007 Mar; 34(3):390-9. PubMed ID: 17222562
[TBL] [Abstract][Full Text] [Related]
86. Overexpression of pitx3 upregulates expression of BDNF and GDNF in SH-SY5Y cells and primary ventral mesencephalic cultures.
Peng C; Fan S; Li X; Fan X; Ming M; Sun Z; Le W
FEBS Lett; 2007 Apr; 581(7):1357-61. PubMed ID: 17350004
[TBL] [Abstract][Full Text] [Related]
87. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
Jensen P; Pedersen EG; Zimmer J; Widmer HR; Meyer M
Brain Res; 2008 Jul; 1218():13-20. PubMed ID: 18513704
[TBL] [Abstract][Full Text] [Related]
88. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.
Jönsson ME; Ono Y; Björklund A; Thompson LH
Exp Neurol; 2009 Sep; 219(1):341-54. PubMed ID: 19555687
[TBL] [Abstract][Full Text] [Related]
89. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
90. 9-Methyl-β-carboline-induced cognitive enhancement is associated with elevated hippocampal dopamine levels and dendritic and synaptic proliferation.
Gruss M; Appenroth D; Flubacher A; Enzensperger C; Bock J; Fleck C; Gille G; Braun K
J Neurochem; 2012 Jun; 121(6):924-31. PubMed ID: 22380576
[TBL] [Abstract][Full Text] [Related]
91. Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency.
Jacobs FM; Smits SM; Noorlander CW; von Oerthel L; van der Linden AJ; Burbach JP; Smidt MP
Development; 2007 Jul; 134(14):2673-84. PubMed ID: 17592014
[TBL] [Abstract][Full Text] [Related]
92. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
Falk T; Zhang S; Sherman SJ
Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
[TBL] [Abstract][Full Text] [Related]
93. Dopaminergic differentiation of human mesenchymal stem cells--utilization of bioassay for tyrosine hydroxylase expression.
Kan I; Ben-Zur T; Barhum Y; Levy YS; Burstein A; Charlow T; Bulvik S; Melamed E; Offen D
Neurosci Lett; 2007 May; 419(1):28-33. PubMed ID: 17475405
[TBL] [Abstract][Full Text] [Related]
94. Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease.
Xu Q; Kanthasamy AG; Reddy MB
Toxicology; 2008 Mar; 245(1-2):101-8. PubMed ID: 18255213
[TBL] [Abstract][Full Text] [Related]
95. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP.
Belzunegui S; San Sebastián W; Garrido-Gil P; Izal-Azcárate A; Vázquez-Claverie M; López B; Marcilla I; Lanciego JL; Luquin MR
Synapse; 2007 Dec; 61(12):1006-12. PubMed ID: 17853434
[TBL] [Abstract][Full Text] [Related]
96. Oxidative stress to dopaminergic neurons as models of Parkinson's disease.
Gille G; Hung ST; Reichmann H; Rausch WD
Ann N Y Acad Sci; 2004 Jun; 1018():533-40. PubMed ID: 15240412
[TBL] [Abstract][Full Text] [Related]
97. Forskolin cooperating with growth factor on generation of dopaminergic neurons from human fetal mesencephalic neural progenitor cells.
Wang X; Li X; Wang K; Zhou H; Xue B; Li L; Wang X
Neurosci Lett; 2004 May; 362(2):117-21. PubMed ID: 15193767
[TBL] [Abstract][Full Text] [Related]
98. Locus coeruleus promotes survival of dopamine neurons in ventral mesencephalon. An in oculo grafting study.
Berglöf E; Strömberg I
Exp Neurol; 2009 Mar; 216(1):158-65. PubMed ID: 19150447
[TBL] [Abstract][Full Text] [Related]
99. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures.
Mercer LD; Kelly BL; Horne MK; Beart PM
Biochem Pharmacol; 2005 Jan; 69(2):339-45. PubMed ID: 15627486
[TBL] [Abstract][Full Text] [Related]
100. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
